New Zealand passed a law expanding medical marijuana access for thousands, while addressing immediate legal protections for some terminally ill patients.
New Zealand has moved to widen access to medical marijuana, setting up a major shift for patients as a referendum on recreational use looms.
The government passed legislation intended to bring medical cannabis to thousands of people over time, replacing a framework that had kept access tightly restricted.. In the same package, the law also creates room for terminally ill patients to use smoked cannabis right away without facing prosecution.
For many patients, the rollout will not be instant. Misryoum reports that most people will need to wait about a year while new regulations, licensing requirements, and quality standards are prepared.
This matters because shifting from a narrow system to one with broader pathways changes not only access, but also how patients and clinicians think about timing, oversight, and legal risk.
Beyond patient access, the legislation would also allow medical marijuana products to be manufactured within New Zealand, with both domestic supply and overseas markets in view. That industrial and regulatory layer is likely to shape how quickly providers and patients can adapt to the new rules.
Health Minister Dr. David Clark said the changes are meant to ease suffering, emphasizing chronic pain and other end-of-life pressures. Clark also pointed to people in palliative care who, in his view, do not have time to wait for the later regulatory steps.
Meanwhile, Dr. Shane Reti, speaking for the opposition, criticized the approach. He argued the law is “lazy and dangerous” because it does not spell out details of the future scheme and also could permit some people to smoke cannabis in public.
Reti said the opposition supports medicinal cannabis but opposes smoking loose-leaf cannabis in public, adding that it is not a medicine. He also described the measure as decriminalising marijuana “by stealth.”
The broader context is that the law arrives ahead of a planned national referendum on recreational marijuana use. That upcoming vote, along with the new medical framework, may influence how public debate, enforcement, and patient guidance evolve over the next phase.